Vanguard Group’s Biotricity, Inc. Common Stock BTCY Stock Holding History

Vanguard Group’s Portfolio BTCY Stock Details BTCY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-102,576	Closed	-$92.3K	–	4428
2024 Q2	$92.3K	Hold	102,576	–	–	﹤0.01%	4238
2024 Q1	$152K	Hold	102,576	–	–	﹤0.01%	4206
2023 Q4	$118K	Sell	102,576 -144,825	-59%	-$193K	﹤0.01%	4282
2023 Q3	$529K	Buy	247,401 +191	+0.1%	+$462	﹤0.01%	4033
2023 Q2	$946K	Hold	247,210	–	–	﹤0.01%	3921
2023 Q1	$690K	Hold	247,210	–	–	﹤0.01%	4024
2022 Q4	$665K	Buy	247,210 +148	+0.1%	+$818	﹤0.01%	4025
2022 Q3	$1.19M	Sell	247,062 -28,678	-10%	-$201K	﹤0.01%	3950
2022 Q2	$2.93M	Hold	275,740	–	–	﹤0.01%	3639
2022 Q1	$3.76M	Sell	275,740 -1,149	-0.4%	-$19.9K	﹤0.01%	3664
2021 Q4	$6.61M	Buy	+276,889	New	+$6.53M	﹤0.01%	3459

Other funds holding BTCY

SFCL

Strengthening Families & Communities LLC Boston, Massachusetts $450M AUM 41.19% 1-Year Est. Return

TWC

TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return

PWA

Provenance Wealth Advisors Fort Lauderdale, Florida $1.05B AUM 18.67% 1-Year Est. Return

PGAM

Princeton Global Asset Management Princeton, New Jersey $698M AUM 31.09% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 29.84% 1-Year Est. Return

Vanguard Group's BTCY Position: Q3 2024 in Review

Vanguard Group sold out of Biotricity, Inc. Common Stock (BTCY) in Q3 2024, closing a stake of 102,576 shares — an estimated $92.3K sold.

Vanguard Group first reported a position in BTCY in Q4 2021 and held it in 11 quarters. The position peaked at $6.61M in Q4 2021. 5 funds tracked by Wall St. Rank hold BTCY as of Q3 2024.

Vanguard Group reported no remaining Biotricity, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
Vanguard Group sold 102,576 Biotricity, Inc. Common Stock shares in Q3 2024, an estimated $92.3K.
Vanguard Group first reported a position in Biotricity, Inc. Common Stock in Q4 2021 and held it in 11 quarters.
Vanguard Group's Biotricity, Inc. Common Stock position peaked at $6.61M in Q4 2021.
5 funds tracked by Wall St. Rank held Biotricity, Inc. Common Stock as of Q3 2024.

Based on Vanguard Group's 13F filing for Q3 2024, filed 13 Nov 2024.